Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$67.97

-8.0211 (-10.56%)

13:19
11/23/16
11/23
13:19
11/23/16
13:19

Eli Lilly price target lowered to $85 from $100 at Cowen

Cowen analyst Steve Scala eliminated solanezumab from his Eli Lilly model which lowered 2018 earnings forecasts to $4.15 from $4.35 and 2019 to $4.75 from $5.30 and a reduction in his price target to $85 from $100. Despite the solanezumab setback, Scala said Outperform rated Eli Lilly has a number of promising new drugs and late-stage agents poised to launch over the next several years that given him confidence in sales and earnings growth prospects.

  • 04

    Dec

LLY Eli Lilly
$67.97

-8.0211 (-10.56%)

11/23/16
JEFF
11/23/16
NO CHANGE
Target $100
JEFF
Buy
Eli Lilly still expects to grow revenue, says Jefferies
Jefferies analyst Jeffrey Holford says that while the solanezumab Phase III trial failure is disappointing, Eli Lilly management expects to grow revenue between 2015 and 2020 while expanding margins. Further, the company is still pursuing the Alzheimer's indication though a number of other programs, Holford tells investors in a research note. The analyst previously estimated a negative solanezumab trial outcome could see the stock down $12. Shares of Lilly are currently down $10.19 to $65.80 in pre-market trading. Holford keeps a Buy rating on Lilly with a $100 price target.
11/23/16
SBSH
11/23/16
NO CHANGE
Target $305
SBSH
Buy
Citi sees four reasons why Biogen Alzheimer's drug can still work
Citi analyst Robyn Karnauska sees four reasons why Biogen's (BIIB) Alzheimer's drug aducanumab can still work following the failure of Eli Lilly's (LLY) solanezumab. The analyst lists difference in mechanism of action, efficacy in an end-point-dependent manner, patient population and endpoints as why she thinks Biogen's drug can have a different outcome than Lilly's. The analyst has a Neutral rating on Biogen with a $305 price target.
11/23/16
JEFF
11/23/16
NO CHANGE
Target $310
JEFF
Buy
Biogen selloff may be an overreaction, says Jefferies
Jefferies analyst Brian Abrahams believes selloff in shares of Biogen (BIIB) following Eli Lilly's (LLY) Alzheimer's failure may be an overreaction. Signals of activity seen for Lilly's sola "do maintain some possibility" that Biogen's aducanumab could "ultimately make it over the line," Abrahams tells investors in a research note. He keeps a Hold rating on Biogen with a $310 price target, however, viewing the risk/reward as balanced.
11/23/16
MSCO
11/23/16
NO CHANGE
Target $73
MSCO
Equal Weight
Eli Lilly price target lowered to $73 from $88 at Morgan Stanley
Morgan Stanley analyst David Risinger lowered his price target for Eli Lilly to $73 after removing Alzheimer's candidate solanezumab from his model. Following this morning's Phase 3 failure, the analyst keeps an Equal Weight rating on the shares. The next catalyst for Eli Lilly is the FDA's action on Jardiance's label by December 4, Risinger tells investors in a research note. He expects Jardiance to get a CV death reduction indication. The analyst notes that his and consensus 2020 estimates have "significant downside" should the indication not be granted. Lilly is down 11%, or $8.28, to $67.71 in afternoon trading.

TODAY'S FREE FLY STORIES

VFC

VF Corp.

$57.14

1.35 (2.42%)

15:36
12/05/16
12/05
15:36
12/05/16
15:36
Technical Analysis
VF Corp. rises, rounding bottom pattern »

The stock is up over 2.3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYGN

Myriad Genetics

$16.66

0.02 (0.12%)

15:30
12/05/16
12/05
15:30
12/05/16
15:30
Options
Vote of confidence in Myriad Genetics will result in big open interest increase »

Vote of confidence in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SMTC

Semtech

$30.30

1.2 (4.12%)

15:25
12/05/16
12/05
15:25
12/05/16
15:25
Conference/Events
Semtech management to meet with B. Riley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

MMI

Marcus & Millichap

$27.78

0.49 (1.80%)

15:25
12/05/16
12/05
15:25
12/05/16
15:25
Hot Stocks
Marcus & Millichap's IPA unit closes sale of Isle at Arrowhead Ranch for $42M »

Marcus & Millichap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

15:25
12/05/16
12/05
15:25
12/05/16
15:25
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

RDI

Reading International

$15.76

-0.17 (-1.07%)

15:24
12/05/16
12/05
15:24
12/05/16
15:24
Conference/Events
Reading International management to meet with B. Riley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

ON

ON Semiconductor

$11.12

0.15 (1.37%)

15:22
12/05/16
12/05
15:22
12/05/16
15:22
Conference/Events
ON Semiconductor management to meet with B. Riley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SUP

Superior Industries

$25.43

0.725 (2.94%)

15:20
12/05/16
12/05
15:20
12/05/16
15:20
Conference/Events
Superior Industries management to meet with B. Riley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 10

    Jan

VFC

VF Corp.

$57.11

1.315 (2.36%)

15:20
12/05/16
12/05
15:20
12/05/16
15:20
Options
5X average daily option volume in VFC driven by a three-way spread »

5X average daily option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIQ

Alliance HealthCare

15:16
12/05/16
12/05
15:16
12/05/16
15:16
Hot Stocks
Alliance HealthCare Radiology forms partnership with Sodexo Healthcare »

Alliance HealthCare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
12/05/16
12/05
15:16
12/05/16
15:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

15:16
12/05/16
12/05
15:16
12/05/16
15:16
Technical Analysis
NASDAQ market internals summary »

Volume is heavier than…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STO

Statoil

$17.74

0.025 (0.14%)

, BP

BP

$35.59

0.11 (0.31%)

15:15
12/05/16
12/05
15:15
12/05/16
15:15
Periodicals
Statoil, BP, Total group awarded first block in Salina auction, Reuters says »

Mexico has awarded a…

STO

Statoil

$17.74

0.025 (0.14%)

BP

BP

$35.59

0.11 (0.31%)

TOT

Total

$48.33

0.55 (1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCO

Clear Channel Outdoor

$5.55

-0.1 (-1.77%)

15:10
12/05/16
12/05
15:10
12/05/16
15:10
Hot Stocks
Clear Channel Airports awarded 10-year contract extension by MNAA »

Clear Channel Airports, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$38.78

0.1735 (0.45%)

, INTC

Intel

$34.16

0.4 (1.18%)

15:06
12/05/16
12/05
15:06
12/05/16
15:06
Hot Stocks
AT&T launches first 5G business customer trial with Intel and Ericsson »

AT&T (T) said it has…

T

AT&T

$38.78

0.1735 (0.45%)

INTC

Intel

$34.16

0.4 (1.18%)

ERIC

Ericsson

$5.16

0.04 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

  • 07

    Dec

  • 14

    Dec

  • 29

    Mar

LLL

L-3 Communications

$157.70

0.47 (0.30%)

15:03
12/05/16
12/05
15:03
12/05/16
15:03
Conference/Events
L-3 Communications to host investor meeting with conference call hookup »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

PARR

Par Pacific

$15.19

0.2 (1.33%)

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Hot Stocks
Whitebox Advisors cuts Par Pacific stake to 16.4% from 18.2% »

Whitebox Advisors, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Conference/Events
U.S. Vice President Biden speaks on financial regulation »

Vice President Biden,…

GBT

Global Blood Therapeutics

$19.10

-0.1 (-0.52%)

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Conference/Events
Global Blood Therapeutics to hold a webcast »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 14

    Dec

  • 15

    Dec

  • 19

    Dec

NEWM

New Media

$15.93

-0.06 (-0.38%)

, DTSI

DTS, Inc.

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Hot Stocks
New Media to replace DTS, Inc. in S&P 600 as of 12/5 close »

S&P SmallCap 600…

NEWM

New Media

$15.93

-0.06 (-0.38%)

DTSI

DTS, Inc.

TSRA

Tessera

$39.30

0.2 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBHC

National Bank

$29.99

0.835 (2.86%)

, ININ

Interactive Intelligence

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Hot Stocks
National Bank to replace Interactive Intelligence in S&P 600 as of 12/5 close »

Genesys is acquiring…

NBHC

National Bank

$29.99

0.835 (2.86%)

ININ

Interactive Intelligence

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDC

Belden

$74.55

0.46 (0.62%)

14:50
12/05/16
12/05
14:50
12/05/16
14:50
Hot Stocks
Belden CEO says targets long-term revenue growth 5%-7% »

Speaking during the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

IMGN

ImmunoGen

$1.88

0.11 (6.21%)

14:49
12/05/16
12/05
14:49
12/05/16
14:49
Hot Stocks
Breaking Hot Stocks news story on ImmunoGen »

ImmunoGen to submit IND…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COUP

Coupa Software

$26.29

-1.49 (-5.36%)

14:49
12/05/16
12/05
14:49
12/05/16
14:49
Options
Coupa Software options imply 19.3% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

IMGN

ImmunoGen

$1.88

0.11 (6.21%)

14:47
12/05/16
12/05
14:47
12/05/16
14:47
Hot Stocks
ImmunoGen reports preclinical data on IMGN632 presented at ASH meeting »

ImmunoGen announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.